Focal Nodular Hyperplasia and Hepatocellular Adenoma: Current views

References

• Wilson T. S., Mcoregor J. W. Focal nodular hyperplasia of the liver: the solitary cirrhotic liver nodule. Can Med Assoc J, 1969, 100: 567–572.
   Google Scholar
• Vilgrain V. Focal nodular hyperplasia. Eur J Radiol, 2006, 58: 236–245.
   Google Scholar
• Karhunen P. J. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol, 1986, 39: 183–188.
   Google Scholar
• Cherqui D., Mathieu D., Zafrani E. S., Dhumeaux D. [Focal nodular hyperplasia and hepatocellular adenoma in women. Current data]. Gastroenterol Clin Biol, 1997, 21: 929–935.
   Google Scholar
• Vilgrain V., üzan F., Brancatelli G., Federle M. P., Zappa M., Menu Y. Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis. Radiology, 2003, 229: 75–79.
   Google Scholar
• Wanless ड. K. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology, 1990, 11: 787–797.
   Google Scholar
• Meyers K. I. Tumors of the liver in children. Surg Oncol, 2007, 16: 195–203.
   Google Scholar
• üngermann I., Elias P., Zizka J., Ryska P., Klzo I. Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol, 2007, 63: 290–294.
   Google Scholar
• Nguyen B. C., Flejoü J. F., Terris B., Belghiti J., Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol, 1999, 23: 1441–1454.
   Google Scholar
• Maillette de Buy Wenniger I., Terpstra V., Beuers U. Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg, 2010, 27: 24–31.
   Google Scholar
• Rebouissou S., Bioulac-Sage P., Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol, 2008, 48: 163–170.
   Google Scholar
• Nahm C. B., Ng K., Lockie P., Samra J. S., Hugh T. J. Focal nodular hyperplasia - a review of myths and truths. J Gastrointest Surg, 2011, 15: 2275–2283.
   Google Scholar
• Scalori A., Tavani A., Gallus S., La Vecchia c., colombo M. Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study. Am J Obstet Gynecol, 2002, 186: 195197.
   Google Scholar
• Mathieu D., Kobeiter H., cherqui D., Rahmouni A., Dhumeaux D. Oral contraceptive intake in women with focal nodular hyperplasia of the liver. Lancet, 1998, 35: 1679–1680.
   Google Scholar
• Heinemann L. A., Weimann A., Gerken G., Thiel c., Schlaud M., DoMinh T. Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study. Eur J Con-tracept Reprod Health Care, 1998, 3: 194–200.
   Google Scholar
• Luciani A., Kobeiter H., Maison P. et al. Focal nodular hyperpla-sia of the liver in men: is presentation the same in men and women ? Gut, 2002, 50: 877–880.
   Google Scholar
• choi B. Y., Nguyen M. H. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol, 2005, 39: 401–412.
   Google Scholar
• Weimann A., Ringe B., Klempnauer J. et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg, 1997, 21: 983–990.
   Google Scholar
• Buell J. F., Tranchart H., cannon R., Dagher I. Management of benign hepatic tumors. Surg Clin North Am, 2010, 90: 719–735.
   Google Scholar
• Di Stasi M., caturelli E., De Sio ड., Salmi A., Buscarini E., Buscarini L. Natural history of focal nodular hyperplasia of the liver: an ultrasound study. J Clin Ultrasound, 1996, 24: 345–350.
   Google Scholar
• Dietrich c. F., Schuessler G., Trojan J., Fellbaum c., Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol, 2005, 78: 704–707.
   Google Scholar
• Kim M. J., Lim H. K., Kim S. H. et al. Evaluation of hepatic focal nodular hyperplasia with contrast-enhanced gray scale harmonic sonography: initial experience. J Ultrasound Med, 2004, 23: 297305.
   Google Scholar
• Kim T. K., Jang H. J., Burns P. N., Murphy-Lavallee J., Wilson S. R. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sono-graphy. AJR Am J Roentgenol, 2008, 190: 58–66.
   Google Scholar
• Terkivatan T., de Wilt J. H., de Man R. A. et al. Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg, 2001, 136: 1033–1038.
   Google Scholar
• caseiro-Alves F., Zins M., Mahfouz A. E. et al. Calcification in focal nodular hyperplasia: a new problem for differentiation from fibrolamellar hepatocellular carcinoma. Radiology, 1996, 198: 889–892.
   Google Scholar
• carlson S. K., Johnson c. D., Bender c. E., Welch T. J. CT of focal nodular hyperplasia of the liver. AJR Am J Roentgenol, 2000, 174: 705–712.
   Google Scholar
• Brancatelli G., Federle M. P., Grazioli L., Blachar A., Peterson M. S., Thaete L. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology, 2001, 219: 61–68.
   Google Scholar
• Valette P. J., Pilleul F., crombe-Ternamian A. MDCT of benign liver tumors and metastases. Eur Radiol, 2003, 13 Suppl 5: M31–41.
   Google Scholar
• Kehagias D., Moulopoulos L., Antoniou A. et al. Focal nodular hyperplasia: imaging findings. Eur Radiol, 2001, 11: 202212.
   Google Scholar
• Federle MP., Brancatelli G. Imaging of benign hepatic masses. Semin Liver Dis, 2001, 21: 237–249.
   Google Scholar
• Terkivatan T., van den Bos I. c., Hussain S. M., Wielopolski P. A., de Man R. A., Ijermans J. N. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study. J Magn Reson Imaging, 2006, 24: 864872.
   Google Scholar
• Mergo P. J., Ros P. R. Benign lesions of the liver. Radiol Clin North Am, 1998, 36: 319–331.
   Google Scholar
• Grazioli L., Morana G., Kirchin M. A., Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology, 2005, 236: 166–177.
   Google Scholar
• Kanematsu M., Goshima S., Watanabe H. et al. Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review. Abdom Imaging, 2012.
   Google Scholar
• Ramirez-Fuentes c., Marti-Bonmati L., Torregrosa A., Del Val A., Martinez c. Variations in the size of focal nodular hyperplasia on magnetic resonance imaging. Radiologia, 2012.
   Google Scholar
• Yang Y., Fu S., Li A. et al. Management and surgical treatment for focal nodular hyperplasia in children. Pediatr Surg Int, 2008, 24: 699–703.
   Google Scholar
• Paradis V., Benzekri A., Dargere D. et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastro-enterology, 2004, 126: 1323–1329.
   Google Scholar
• Bioulac-Sage P., Balabaud c., Bedossa P. et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol, 2007, 46: 521–527.
   Google Scholar
• Perrakis A., Demir R., Muller V. et al. Management of the focal nodular hyperplasia of the liver: evaluation of the surgical treatment comparing with observation only. Am J Surg, 2012.
   Google Scholar
• Di carlo I., Pulvirenti E., Toro A., Priolo G. D. Adenoma or atypical hepatic focal nodular hyperplasia: role of preoperative imaging and laparoscopic treatment. Surg Laparosc Endosc Percutan Tech, 2010, 20: 105–109.
   Google Scholar
• Huang D., chen Y., Zeng Q. et al. Transarterial embolization using pingyangmycin lipiodol emulsion and polyvinyl alcohol for the treatment of focal nodular hyperplasia of the liver. Hepatogastro-enterology, 2011, 58: 1736–1741.
   Google Scholar
• Amesur N., Hammond J. S., Zajko A. B., Geller D. A., Gamblin T. c. Management of unresectable symptomatic focal nodular hyperplasia with arterial embolization. J Vasc Interv Radiol, 2009, 20: 543–547.
   Google Scholar
• Hedayati P., VanSonnenberg E., Shamos R., Gillespie T., McMullen W. Treatment of symptomatic focal nodular hyper-plasia with percutaneous radiofrequency ablation. J Vasc Interv Radiol, 2010, 21: 582–585.
   Google Scholar
• Malumbres M., Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer, 2003, 3: 459–465.
   Google Scholar
• Lerman M. I., Minna J. D. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res, 2000, 60: 6116–6133.
   Google Scholar
• Dammann K., Li c., Yoon J. H., Chin P. L., Bates s., Pfeifer G. P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet, 2000, 25: 315–319.
   Google Scholar
• Lehmann U., Berg-Ribbe I., Wingen L. U. et al. Distinct methyla-tion patterns of benign and malignant liver tumors revealed by quantitative methylation profiling. Clin Cancer Res, 2005, 11: 3654–3660.
   Google Scholar
• Di Gioia s., Bianchi P., Destro A. et al. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver. BMC Cancer, 2006, 6: 89.
   Google Scholar
• zucMAN-Rossi J., Jeannot E., Nhieu J. T. et al. Genotype-pheno-type correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology, 2006, 43: 515–524.
   Google Scholar
• Chen Y. J., Chen P. J., Lee M. C., Yeh s. H., Hsu M. T., Lin C. H. Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization. Genes Chromosomes Cancer, 2002, 35: 138–143.
   Google Scholar
• Chen Y. W., Jeng Y. M., Yeh s. H., Chen PJ. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology, 2002, 36: 927–935.
   Google Scholar
• üshita A., Itamoto T., Amano H., ühdan H., Tashiro H., Asahara T. Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia. J Hepatobiliary Pancreat Surg, 2008, 15: 200–203.
   Google Scholar
• Deneve J. L., Pawlik T. M., Cunningham S. et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol, 2009, 16: 640–648.
   Google Scholar
• Vetelainen R., Erdügan D., de Graaf W. et al. Liver adenomato-sis: re-evaluation of aetiology and management. Liver Int, 2008, 28: 499–508.
   Google Scholar
• Ercülani G., Grazi G. L., Pinna A. D. Liver transplantation for benign hepatic tumors: a systematic review. Dig Surg, 2010, 27: 68–75.
   Google Scholar
• Daga B. V., shah V. R., More R. B. CT scan diagnosis of hepatic adenoma in a case of von Gierke disease. Indian J Radiol Imaging, 2012, 22: 54–57.
   Google Scholar
• van Aalten s. M., de Man R. A., JN I. J., Terkivatan T. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg, 2012, 99: 911–916.
   Google Scholar
• van Aalten s. M., Terkivatan T., de Man R. A. et al. Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences. Dig Surg, 2010, 27: 61–67.
   Google Scholar
• van Aalten s. M., Witjes C. D., de Man R. A., Ijzermans J. N., Terkivatan T. Can a decision-making model be justified in the management of hepatocellular adenoma ? Liver Int, 2012, 32: 2837.
   Google Scholar
• Noels J. E., van Aalten s. M., van der Windt D. J. et al. Management of hepatocellular adenoma during pregnancy. J Hepatol, 2011, 54: 553–558.
   Google Scholar
• Micchelli s. T., Vivekanandan P., Büitnütt J. K., Pawlik T. M., Chüti M. A., Türbensün M. Malignant transformation of hepatic adenomas. Mod Pathol, 2008, 21: 491–497.
   Google Scholar
• Farges O., Dokmak s. Malignant transformation of liver adenoma: an analysis of the literature. Dig Surg, 2010, 27: 32–38.
   Google Scholar
• Kapp N., Curtis K. M. Hormonal contraceptive use among women with liver tumors: a systematic review. Contraception, 2009, 80: 387–390.
   Google Scholar
• Bioulac-sage P., Taouji s., Possenti L., Balabaud C. Hepato-cellular adenoma subtypes: the impact of overweight and obesity. Liver Int, 2012, 32: 1217–1221.
   Google Scholar
• stoot J. H., Coelen R. J., De Jong M. C., Dejong C. H. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford), 2010, 12: 509–522.
   Google Scholar
• Bioulac-sage P., Laumonier H., Couchy G. et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology, 2009, 50: 481–489.
   Google Scholar
• van Aalten s. M., Verheij J., Terkivatan T., Dwarkasing R. s., de Man R. A., Ijzermans J. N. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol, 2011, 55: 120–125.
   Google Scholar
• Assy N., Nasser G., Djibre A., Beniashvili घ., Elias s., Zidan J. Characteristics of common solid liver lesions and recommendations for diagnostic workup. World J Gastroenterol, 2009, 15: 3217–3227.
   Google Scholar
• Charny C. K., Jarnagin W. R., schwartz L. H. et al. Management of 155 patients with benign liver tumours. Br J Surg, 2001, 88: 808–813.
   Google Scholar
• Manichon A. F., Bancel B., Durieux-Millon M. et al. Hepatocel-lular adenoma: evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions. HPB Surg, 2012.
   Google Scholar
• Bieze M., van den Esschert J. W., Nio C. Y. et al. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol, 2012, 199: 26–34.
   Google Scholar
• van den Esschert J. W., Bieze M., Beuers u. H., van Gulik T. M., Bennink R. J. Differentiation of hepatocellular adenoma and focal nodular hyperplasia using 18F-fluorocholine PET/CT. Eur J Nucl Med Mol Imaging, 2011, 38: 436–440.
   Google Scholar
• Wilson C. H., Manas D. M., French J. J. Laparoscopic liver resection for hepatic adenoma in pregnancy. J Clin Gastroenterol, 2011, 45: 828–833.
   Google Scholar
• Herman P., Coelho F. F., Perini M. V., Lupinacci R. M., D’Albuquerque L. A., Cecconello I. Hepatocellular adenoma: an excellent indication for laparoscopic liver resection. HPB (Oxford), 2012, 14: 390–395.
   Google Scholar
• Abu Hilal M., Di Fabio F., Wiltshire R. D., Hamdan M., Layfield D. M., Pearce NW. Laparoscopic liver resection for hepatocellular adenoma. World J Gastrointest Surg, 2011, 3: 101105.
   Google Scholar
• Kammula u. s., Buell J. F., Labow D. M., Rosen s., Millis J. M., Posner M. C. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer, 2001, 30: 141–146.
   Google Scholar
• Perrakis A., Muller v., Oeckl K. et al. Indications and long-term outcome after elective surgery for hepatocellular adenoma. Am Surg, 2012, 78: 80–85.
   Google Scholar
• Cho s. W., Marsh J. W., steel J. et al. Surgical management of hepatocellular adenoma: take it or leave it ? Ann Surg Oncol, 2008, 15: 2795–2803.
   Google Scholar
• santambrogio R., Marconi A. M., Ceretti A. P., Costa M., Rossi G., Opocher E. Liver transplantation for spontaneous intra-partum rupture of a hepatic adenoma. Obstet Gynecol, 2009, 113: 508–510.
   Google Scholar
• van Vledder M. G., van Aalten s. M., Terkivatan T., de Man R. A., Leertouwer T., Ijzermans J. N. Safety and efficacy of radiofrequency ablation for hepatocellular adenoma. J Vasc Interv Radiol, 2011, 22: 787–793.
   Google Scholar
• Rhim H., Lim H. K., Kim Y. s., Choi D. Percutaneous radio-frequency ablation of hepatocellular adenoma: initial experience in 10 patients. J Gastroenterol Hepatol, 2008, 23: 422–427.
   Google Scholar
• Mathe E. RASSF1A, the new guardian of mitosis. Nat Genet, 2004, 36: 117–118.
   Google Scholar
• Nathke I. S. The adenomatous polyposis coli protein: the Achilles heel of the gut epithelium. Annu Rev Cell Dev Biol, 2004, 20: 337366.
   Google Scholar
• Chiles T. C. Regulation and function of cyclin D2 in B lymphocyte subsets. J Immunol, 2004, 173: 2901–2907.
   Google Scholar
• Jeannot E., Mellottee L., Bioulac-sage P. et al. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes, 2010, 59: 1836–1844.
   Google Scholar
• Bioulac-sage P., Laumonier H., Laurent C., Zucman-Rossi J., Balabaud C. Hepatocellular adenoma: what is new in 2008. Hepatol Int, 2008, 2: 316–321.
   Google Scholar